The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Chemotherapy may increase Alzheimer disease (AD) risk by impacting shared biological pathways. Understanding these links is crucial for public health, especially with rising AD and cancer survivor populations.
Area Of Science
- Neuroscience
- Oncology
- Geriatrics
Background
- Alzheimer disease (AD) is a leading cause of death in the elderly, with cases projected to double by 2060.
- Cancer survivors are increasing, and many experience cognitive impairment after chemotherapy.
- Identifying modifiable risk factors for AD is a public health priority.
Purpose Of The Study
- To explore shared biological pathways between Alzheimer disease and chemotherapy-related cognitive impairment.
- To understand why some chemotherapy patients may face a higher risk of developing AD.
- To review key molecular and cellular mechanisms implicated in both conditions.
Main Methods
- Literature review of biologically plausible pathways connecting AD and chemotherapy-induced cognitive deficits.
- Analysis of shared risk factors and underlying mechanisms.
- Synthesis of current research on neuroinflammation, oxidative stress, and genetic factors.
Main Results
- Shared pathways include APOE E4 allele, neuroinflammation, oxidative stress, DNA damage, and mitochondrial dysfunction.
- Neuronal/synaptic loss, cellular senescence, BDNF signaling, white matter damage, and vascular dysfunction are also implicated.
- Tau pathology and transposable element reactivation represent further commonalities.
Conclusions
- Chemotherapy may exacerbate or accelerate AD pathology through shared biological mechanisms.
- Further research is needed to elucidate these connections and develop preventative strategies.
- Understanding these links can inform risk assessment and management for cancer survivors at risk for AD.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...